Nanoparticles
How DIANT Pharma is Transforming Nanoparticle Manufacturing
Antonio Costa, Ph.D.
DIANT Pharma
PAO-04-24-PHEX-26Jul 02, 2025
Exosomes
Five Exosome Biotechs to Watch: July 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-01Jul 01, 2025
Biomanufacturing
What are the most significant manufacturing hurdles in biopharma and how can they be addressed?
Pharma's Almanac
PAO-06-25-RT-02Jun 30, 2025
CGT
ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility to Advance Cell and Gene Therapy
ProBio Inc
PR-06-25-NI-11Jun 30, 2025
Viral Vector CDMOs
Breaking Through the Noise in Viral Vector CDMO Marketing
Emilee Kudla
Pharma's Almanac
PAO-06-25-NI-10Jun 25, 2025
Gene Editing
What are the key ethical and regulatory considerations as gene editing technologies advance toward widespread clinical use?
Pharma's Almanac
PAO-05-25-RT-02Jun 17, 2025
Nanoscale
Addressing Drug Delivery Challenges at the Nanoscale
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-25-NI-07Jun 16, 2025
Exosomes
Nature’s Nanocarriers: The Evolving Role of Exosomes in Targeted Drug Delivery
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-04May 13, 2025
AAV
Gene Therapy at a Crossroads: Rethinking AAV Amid Industry Resets
Daniel Smith, Ph.D.
Nice Consulting
PAO-05-25-NI-02May 06, 2025
Xenotransplantation
CRISPR-Edited Pig Organs and the Promise of Xenotransplantation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-13Apr 25, 2025
RNA Editing
Rewriting the Script: The Past, Present, and Future of RNA Editing Therapeutics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-09Apr 18, 2025
Oncology
From Chemo to Advanced Therapies: New Frontiers in Oncology
Serene Lee
Nice Insight
PAO-25-30-29Apr 15, 2025
Gene Therapy
Gene Therapy at 30: Milestones, Setbacks, and a Path Forward
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-28Apr 14, 2025
Multispecific Abs
Strategic Biomanufacturing Partner for Multispecific Antibodies
Jina Kim; Busol Park; Youngsun Kim
Samsung Biologics
PAO-04-25-CL-04Apr 14, 2025
Cell Therapy
Expanding the Frontiers of Cell Therapy: Veterinary Applications and Translational Insights
April Stanley, MS MBA; Sophie Lutter, Ph.D.
Nice Insight
PAO-03-25-NI-07Mar 26, 2025
RNA
Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate
Cynthia A. Challener, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
PAO-03-25-NI-06Mar 26, 2025
RNA
What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?
Pharma's Almanac
PAO-03-25-RT-02Mar 26, 2025
OMVs and EVs
Driving Therapeutic Innovation with OMVs and EVs
Ola Tuvesson; Isa Lindgren, Ph.D.
NorthX Biologics
PAO-02-25-CL-09Mar 21, 2025
RNA
Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-24Mar 21, 2025
Aging
Resetting the Biological Clock: OKSM and the Reversal of Aging
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-22Mar 19, 2025